11-113388000-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_178510.2(ANKK1):c.116C>A(p.Ala39Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,570,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178510.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKK1 | NM_178510.2 | c.116C>A | p.Ala39Glu | missense_variant | 1/8 | ENST00000303941.4 | |
ANKK1 | XM_011542736.3 | c.116C>A | p.Ala39Glu | missense_variant | 1/9 | ||
ANKK1 | XM_017017475.2 | c.116C>A | p.Ala39Glu | missense_variant | 1/9 | ||
ANKK1 | XM_011542737.3 | c.116C>A | p.Ala39Glu | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKK1 | ENST00000303941.4 | c.116C>A | p.Ala39Glu | missense_variant | 1/8 | 1 | NM_178510.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000174 AC: 31AN: 177654Hom.: 0 AF XY: 0.000193 AC XY: 19AN XY: 98336
GnomAD4 exome AF: 0.000147 AC: 208AN: 1418050Hom.: 0 Cov.: 31 AF XY: 0.000151 AC XY: 106AN XY: 702274
GnomAD4 genome AF: 0.000217 AC: 33AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.116C>A (p.A39E) alteration is located in exon 1 (coding exon 1) of the ANKK1 gene. This alteration results from a C to A substitution at nucleotide position 116, causing the alanine (A) at amino acid position 39 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at